| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 05/08/2008 | WO2008053257A1 A pharmaceutical composition having antipsychotic, antidepressant or antiepiieptic activity with reduced side effect |
| 05/08/2008 | WO2008053131A1 Hydroxamates as inhibitors of histone deacetylase |
| 05/08/2008 | WO2008053049A1 Modulators of cell adhesion molecules and use thereof |
| 05/08/2008 | WO2008053031A1 Compounds which potentiate ampa receptor and uses thereof in medicine |
| 05/08/2008 | WO2008053011A1 Dmae as sole agent for the treatment of mild cognitive impairment |
| 05/08/2008 | WO2008052953A1 The use of pramipexole or a salt thereof for the treatment of parkinson's disease |
| 05/08/2008 | WO2008052907A1 Substituted 2-imidazoles as modulators of the trace amine associated receptors |
| 05/08/2008 | WO2008052899A1 Ether derivatives dual modulators of the 5-ht2a and d3 receptors |
| 05/08/2008 | WO2008052804A1 Thiazolhydrazides for treatment of neurodegenerative diseases |
| 05/08/2008 | WO2008052766A2 Cationic colloidal carriers for delivery of active agents to the blood-brain barrier in the course of neuroinflammatory diseases |
| 05/08/2008 | WO2008052734A1 Heterocyclic compounds as antiinflammatory agents |
| 05/08/2008 | WO2008052417A1 Controlled porosity osmotic pump tablet of high permeable drugs and the preparation method thereof |
| 05/08/2008 | WO2008052355A1 Method of treating alzheimer's disease |
| 05/08/2008 | WO2008052354A1 Method of treating demyelination diseases |
| 05/08/2008 | WO2008052256A1 Prevention and reversal of chemotherapy-induced peripheral neuropathy |
| 05/08/2008 | WO2008039359A3 Bicyclic pyrimidine kinase inhibitors |
| 05/08/2008 | WO2008036410A3 Methods and compositions for treating amyotrophic lateral sclerosis (als) |
| 05/08/2008 | WO2008034863A3 Sulfonylpyrazoline carboxamidine derivatives as 5-ht6 antagonists |
| 05/08/2008 | WO2008034735A3 4-oxo-2,3,4,5-tetrahydro-benzo[b][1,4]diazepine derivatives |
| 05/08/2008 | WO2008024371A3 Multimediator transporter inhibitors for use in treatment of central nervous system disorders |
| 05/08/2008 | WO2008002591A3 Methods for treating atherosclerosis |
| 05/08/2008 | WO2007146138A3 Thiadiazole compounds and methods of use thereof |
| 05/08/2008 | WO2007135529A3 Azabenzimidazolyl compounds as mglur2 potentiators |
| 05/08/2008 | WO2007107789A3 Treatment of cns conditions |
| 05/08/2008 | WO2007056388A3 Compositions and methods for modulating poly (adp-ribose) polymerase activity |
| 05/08/2008 | WO2007038271A9 Amino-5- [4- (difluoromethoxy) phenyl] -5-phenylimidazolone compounds as inhibitors of the beta-secretase (bace) |
| 05/08/2008 | WO2006056487A3 Peptides useful as dual caspase-2/-6 inhibitors and their biological applications |
| 05/08/2008 | US20080109035 Methods and Compositions for Repairing Common Peroneal Nerve Lesions |
| 05/08/2008 | US20080108840 Useful for inhibiting the aggregation of amyloid protein to form amyloid deposit |
| 05/08/2008 | US20080108809 Benzothiazole derivatives with activity as adenosine receptor ligands |
| 05/08/2008 | US20080108808 Dipeptidyl peptidase inhibitors |
| 05/08/2008 | US20080108807 Immunosuppressants; autoimmune disease; antiinflammatory agents; multiple sclerosis; rheumatic diseases; antiarthritic agents; aids; for example, 2-{6-[3-Amino-piperidin-1-yl]-3-ethyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl}-benzonitrile |
| 05/08/2008 | US20080108696 Phytoestrogenic Formulations for Alleviation or Prevention of Neurodegenerative Diseases |
| 05/08/2008 | US20080108691 For example, 1-(4-Cyano-2-ethyl-3-(trifluoromethyl)phenyl-1-carbamoyl)-3-hydroxy-pyrrolidine-2-carboxylic acid methyl ester; may be used in treatment of diseases or disorders associated with androgen receptor activity, such as maintenance of muscle strength and function in the elderly |
| 05/08/2008 | US20080108683 4-phenylthiazole and 4-phenylimidizole derivatives and their use as medicaments for the treatment of neurodegenerative diseases, pain and epilepsy |
| 05/08/2008 | US20080108679 Isoxazolic Derivative to Relieve Neuropathic Pain |
| 05/08/2008 | US20080108676 Benzothiazolecarboxamides |
| 05/08/2008 | US20080108669 Use 541 |
| 05/08/2008 | US20080108663 Cyclopropyl Piperidine Glycine Transporter Inhibitors |
| 05/08/2008 | US20080108660 such as 4-{[4-({[(3-isopropyl-2-oxo-2,3-dihydro-1H-benzimidazol-1-yl)carbonyl]amino}methyl)piperidin-1-yl]methyl}tetrahydro-2H-pyran-4-carboxylic acid; serotonin receptor agonist; antidepressant, anxiolytic agent, analgesic, cognition activator; less toxicity, good absorption, and metabolic stability |
| 05/08/2008 | US20080108654 Protein kinase inhibitors; antitumor agents; such as 5-methyl-1-quinol-4-ylmethyl-3-(4-trifluoromethanesulfonylphenyl)imidazolidine-2,4-dione trifluoroacetate |
| 05/08/2008 | US20080108653 Tripeptidyl peptidase inhibitors |
| 05/08/2008 | US20080108652 Acute/chronic inflammatory disease of peripheral organs and central nervous system (CNS) |
| 05/08/2008 | US20080108650 Such as 3-isobutyryl-2-isopropyl pyrazolo[1,5-a]pyridine; for treatment of Parkinson's disease, Huntington's disease, Alzheimer's disease, and schizophrenia |
| 05/08/2008 | US20080108645 Dihydrotetrabenazines And Pharmaceutical Compositions Containing Them |
| 05/08/2008 | US20080108643 synergistic mixture of Memantine derivatives (5 - 20 mg per day) and dextromethorphan (15 - 30 mg); Pervasive Developmental Disorders (PDD); sensory integration problems, verbal and non-verbal communication, social interactions, and leisure or play activities; side effect reduction |
| 05/08/2008 | US20080108641 Compounds for treating inflammatory disorders, demyelinating disdorders and cancers |
| 05/08/2008 | US20080108633 Administering (S)-5-bromo-N2-(1-(5-fluoropyridin-2-yl)ethyl)-N4-(5-isopropoxy-1H-pyrazol-3-yl)pyrimidine-2,4-diamine as analgesic |
| 05/08/2008 | US20080108628 Treatment of diseases or disorders mediated by T lymphocytes and/or PKC; may be coadminstered with an immunosuppressant, immunomodulatory, anti-inflammatory, antiproliferative or anti-diabetic drug |
| 05/08/2008 | US20080108627 9-[(3-hydroxy-5-methoxyphenyl)amino]-1,2-dihydrothieno[3,2-f]quinoline-8-carbonitrile 3,3-dioxide; protein tyrosine kinases inhibitor, especially erythropoetin-producing hepatoma amplified sequence (Eph) receptors antagonist; antitumor, angiogenesis inhibitor, neurodegenerative diseases |
| 05/08/2008 | US20080108625 Substituted Triazole Derivatives as Oxytocin Antagonists |
| 05/08/2008 | US20080108624 Methylene Dipiperidine Derivatives |
| 05/08/2008 | US20080108623 N-(4-(1-(2,6-difluorobenzyl)-5(((2-methoxyethyl)(methyl)amino)methyl)-2,4-dioxo-3-(2-pyridinyl)-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-6-yl)phenyl)-N'-methoxyurea; gonadotropin releasing hormone (GnRH) antagonist; sex hormone dependent disease, antitumor agent |
| 05/08/2008 | US20080108622 Administering allosteric adenosine A1 receptor enhancer in conjunction with opioid analgesics or 2-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid (AMPA)/kainate antagonists for alleviating postoperative pain |
| 05/08/2008 | US20080108619 Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses |
| 05/08/2008 | US20080108615 such as 4-(1-Hydroxyimino-indan-5-yl)-5-pyridin-4-yl-1H-imidazole-2-carboxylic acid (2-morpholin-4-yl-ethyl)-amide; anticarcinogenic agents, neurodegenerative diseases, brain disorders, stroke, antischemic agent |
| 05/08/2008 | US20080108614 Substituted 2-Amino-Quinazolin-4-Cn Compounds for Use in the Treatment of Cns Disorders, Pain, Stroke, Addiction and Epilepsy, their Preparation and Use as Intermediates |
| 05/08/2008 | US20080108606 Side effect reduction; antiproliferative agents; schizophrenia |
| 05/08/2008 | US20080108605 Anxiolytic agents with reduced sedative and ataxic effects |
| 05/08/2008 | US20080108603 Combination therapy for the treatment of pain |
| 05/08/2008 | US20080108600 Polycyclic Pyridines as Potassium Ion Channel Modulators |
| 05/08/2008 | US20080108599 Heterocyclic Tetracyclic Tetrahydrofuran Derivatives As 5Ht2 Inhibitors In The Treatment Of Cns Disorders |
| 05/08/2008 | US20080108597 New Use of Quetiapine |
| 05/08/2008 | US20080108596 Antiserotonine agents; psycholgical disorders; headaches; kits |
| 05/08/2008 | US20080108591 2-amino-3,6-dihydro-4-dimethyl-amino-6-ethyl-1,3,5-triazine hydrochloride; advanced glycosylation end-products inhibitor;antidiabetic, insulin resistance, neurodegenerative disorders, renal complications, atherosclerosis, angiopathy |
| 05/08/2008 | US20080108574 Melanocortin receptor mediated modulation of neurogenesis |
| 05/08/2008 | US20080108568 administering a sulfonamide compound containing quinoline and 1,4-diazapine rings, with a nitric oxide enhancer selected from the group consisting of a PDE5 inhibitor, a nitric oxide donor molecules, or a HMG Co A Reductase |
| 05/08/2008 | US20080108566 Analogues of GLP-1 |
| 05/08/2008 | US20080108562 administering PTH receptor agonist; bone loss, bone fracturing, and/or reduce pain |
| 05/08/2008 | US20080107763 Use of the neurotoxic component of a botulinum toxin for treating a spastic muscle |
| 05/08/2008 | US20080107762 Reducing a cholinergic influenced secretion; treating smooth muscle disorders such as spasms |
| 05/08/2008 | US20080107756 Lithium combinations, and uses related thereto |
| 05/08/2008 | US20080107755 Administer sodium selenite with an antioxidant to subject with reduced expression of Gadd45b in cerebral cortex, liver, intestinal, skeletal muscle tissue; antioxidant is alkylated diphenylamines, N-alkylated phenylenediamines, phenyl- alpha -naphthylamine; Alzheimer's, Pick's disease, supranuclear palsy |
| 05/08/2008 | US20080107745 Controlled release sterile injectable aripiprazole formulation and method |
| 05/08/2008 | US20080107720 Topical delivery of codrugs |
| 05/08/2008 | US20080107719 Transdermal drug delivery system |
| 05/08/2008 | US20080107664 Using mylein basic protein to prepare vaccine for treatment of autoimmune disease |
| 05/08/2008 | US20080107655 Interferon specific immunoglobulin for use in diagnosis, prevention and treatment of autoimmune diseases |
| 05/08/2008 | US20080107633 Cultures of human CNS neural stem cells |
| 05/08/2008 | US20080107608 selective modulators of corticotropin -releasing factor (CRF) receptors, central and periphereal nervous system disorders; antidepressant, anxiolytic agent; stress, cardiovascular disorders, and eating disorders; probes for the localization of CRF receptors |
| 05/08/2008 | US20080107603 Administering L-ergothioneine; Alzheimer's disease, multiple sclerosis, stroke, traumatic brain injury, spinal cord injuries |
| 05/08/2008 | US20080107600 Gene Marker And Composition For Diagnosis And Treatment Of Neurological Disorders And Diseases And Use Of The Same |
| 05/08/2008 | DE202008002797U1 Medikamentengestützter Nikotinentzug Medication-assisted smoking cessation |
| 05/08/2008 | DE102006051796A1 Triaza-benzo[e]azulenderivate Triaza-benzo [e] azulene derivatives |
| 05/08/2008 | DE102006049452A1 Substituierte Tetrahydropyrolopiperazin-Verbindungen und deren Verwendung in Arzneimitteln Tetrahydropyrolopiperazin substituted compounds and their use in medicaments |
| 05/08/2008 | CA2704279A1 Method of treating demyelination diseases |
| 05/08/2008 | CA2704145A1 Butyrylcholinesterase inhibitors and their use in the treatment of neurodegenerative diseases |
| 05/08/2008 | CA2685724A1 New use 541 |
| 05/08/2008 | CA2668554A1 Method for identification of compound having anti-anxiety effect |
| 05/08/2008 | CA2668491A1 Novel cannabinoid receptor ligands, pharmaceutical compositions containing them, and processes for their preparation |
| 05/08/2008 | CA2668454A1 Substituted 2-imidazoles |
| 05/08/2008 | CA2668384A1 A pharmaceutical composition having antipsychotic, antidepressant or antiepileptic activity with reduced side effect |
| 05/08/2008 | CA2668321A1 Pyrazolyl derivatives with analgesic activity and therefore useful in the treatment or prophylaxis of pain |
| 05/08/2008 | CA2668070A1 Hydroxamates as inhibitors of histone deacetylase |
| 05/08/2008 | CA2668008A1 Prevention and reversal of chemotherapy-induced peripheral neuropathy |
| 05/08/2008 | CA2667983A1 Dmae as sole agent for the treatment of mild cognitive impairment |
| 05/08/2008 | CA2667962A1 Heterocyclic compounds as antiinflammatory agents |
| 05/08/2008 | CA2667949A1 Methods for treating depression |
| 05/08/2008 | CA2667924A1 The use of pramipexole or a salt thereof for the treatment of parkinson's disease |
| 05/08/2008 | CA2667909A1 Treatment of pervasive developmental disorders |